SEC Filing Summary: Global Medical REIT Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Global Medical REIT Inc. on July 5, 2016, reporting events occurring on June 28, 2016. The filing details the entry into a material definitive agreement for a public offering of common stock. Note: The request metadata references "Chiron Real Estate Inc.," but the filing text explicitly identifies the registrant as "Global Medical REIT Inc."
Key Financial Metrics and Transaction Details
- Offering Size: 13,043,479 shares of Common Stock.
- Public Price: $10.00 per share.
- Net Proceeds per Share: $9.30 (net of underwriting discounts, advisory fees, and commissions).
- Total Gross Proceeds: Approximately $130.4 million.
- Over-Allotment Option: Underwriters granted a 30-day option to purchase up to 1,956,521 additional shares.
- Closing Date: July 1, 2016.
Material Changes and Use of Proceeds
The filing reports a significant capital raise intended to alter the company's capital structure and expand its portfolio. The net proceeds are allocated as follows:
- Debt Repayment: Approximately $14.7 million to repay a mortgage loan from Capital One, National Association.
- Debt Repayment: $10.0 million to repay outstanding 8.0% convertible debentures held by ZH USA, LLC.
- Debt Repayment: $1.5 million to repay an interest-free loan from ZH, USA, LLC.
- Acquisitions: Approximately $9.2 million to acquire the Wyomissing Facilities.
- Portfolio Expansion: Approximately $84.2 million reserved for the acquisition of additional properties.
Guidance, Outlook, and Risks
Management intends to utilize the majority of the net proceeds ($84.2 million) to acquire properties for its investment portfolio, signaling an expansion strategy. The filing notes customary indemnification obligations to underwriters regarding liabilities under the Securities Act. No specific forward-looking financial guidance or risk factors beyond standard underwriting terms are detailed in this specific 8-K text.
Key Facts for Investor Verification
- Verify the actual closing date and final share count, including any exercise of the 30-day over-allotment option.
- Confirm the successful repayment of the specified debts (Capital One mortgage, ZH USA debentures, and ZH USA interest-free loan).
- Monitor the deployment of the $84.2 million designated for new property acquisitions to ensure alignment with the stated investment strategy.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific termination provisions and indemnification details.